Remitly (RELY) Files Form 144; 10b5-1 Sales Total 54,508 Shares

Rhea-AI Filing Summary

Remitly Global, Inc. (RELY) Form 144 notifies the SEC of a proposed sale of 5,748 common shares, with an aggregate market value of $109,499.40, planned for 08/25/2025 on NASDAQ. The shares were acquired as restricted stock units on 05/25/2024 and no cash payment arrangement is indicated. The filing also discloses three prior 10b5-1 plan sales by the same account during June–August 2025 totaling 54,508 shares for gross proceeds of approximately $1,070,814.91. The filer certifies no undisclosed material adverse information and references a 10b5-1 plan where applicable.

Positive

• Proper regulatory disclosure of a proposed sale and recent 10b5-1 sales, including broker and transaction details
• Clear origin of the securities as restricted stock units with acquisition date noted (05/25/2024)

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider plan sale disclosed; amounts are small relative to 206.2M shares outstanding and unlikely to be materially market-moving.

The Form 144 shows a planned sale of 5,748 shares and recent executed 10b5-1 sales totaling 54,508 shares. Against a reported 206,193,217 shares outstanding, the cumulative sales represent an immaterial fraction of float (<0.03%). From a market-impact perspective, this disclosure is routine compliance by an insider or related account and should not materially affect valuation. The filing confirms these shares originated as restricted stock units, indicating standard equity compensation monetization rather than a company financing or major insider exit.

Corporate Governance Expert

TL;DR: Filing reflects proper Rule 144/10b5-1 procedures; disclosure supports governance transparency but contains no red flags.

The notice documents acquisition date (05/25/2024), nature of grant (RSUs), planned sale date, and broker details, and it references prior 10b5-1 plan sales. This level of disclosure aligns with regulatory expectations for reporting proposed transactions by insiders and those subject to Rule 144 aggregation. No indications of undisclosed material information are asserted by the signer. Given the small scale of the transactions, there are no immediate corporate governance concerns evident in the filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5748	109499.40	206193217	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/25/2024	Restricted Stock Units	Issuer			5748	05/25/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SAEMA SOMALYA 401 Union Street, Suite 1000 SEATTLE WA 98101	Common	08/07/2025	18045	344215.59
10b5-1 Sales for SAEMA SOMALYA 401 Union Street, Suite 1000 SEATTLE WA 98101	Common	06/25/2025	18045	359579.25
10b5-1 Sales for SAEMA SOMALYA 401 Union Street, Suite 1000 SEATTLE WA 98101	Common	06/11/2025	18418	367020.07

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Remitly (RELY) Form 144 report?

The filing reports a proposed sale of 5,748 common shares valued at $109,499.40, planned for 08/25/2025, and discloses prior 10b5-1 sales in June–August 2025.

How were the shares being sold acquired?

The shares were acquired as restricted stock units on 05/25/2024 and the filing shows no cash payment arrangement for the grant.

How large are the recent insider sales relative to shares outstanding for RELY?

The filing lists 54,508 shares sold in the past three months and a proposed sale of 5,748, versus 206,193,217 shares outstanding—an immaterial fraction of the total.

Were prior sales executed under a 10b5-1 plan?

Yes. The three listed prior sales are labeled as 10b5-1 Sales from the same account, with dates in June and August 2025.

On which exchange will the proposed sale occur?

The filing specifies the NASDAQ as the securities exchange for the proposed sale on 08/25/2025.